Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

Director, The Women’s Heart and Vascular Center at Mount Sinai Fuster Heart

Director, Center for Interventional Cardiovascular Research and Clinical Trials

Endowed Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes

Professor of Medicine (Cardiology)

Professor of Population Health Science and Policy

Icahn School of Medicine at Mount Sinai

Clinical Interests:

Cardiovascular Disease in Women

Disparities in care of vulnerable patients

Antithrombotic Therapy for Secondary Prevention

Percutaneous Coronary intervention with Stents

Contrast-Induced Acute Kidney Injury (AKI)

Cardiometabolic Health- Population health, Outcomes

Primary and Secondary prevention for cardiovascular events

Clinical Trial design, and analysis in cardiovascular medicine

Population health outcomes

Personalized Medicine/Risk scores

Roxana Mehran, MD, is an internationally renowned interventional cardiologist, clinical research expert and trialist in the field of cardiovascular disease. She is amongst the most prolific researchers in the United States and is a globally-respected leader of an academic research center focused on designing and implementing randomized clinical trials, outcomes research projects, and high impact academic publications. She has served as principal investigator for numerous global studies, developed important practice guidelines for treating patients with cardiovascular disease.  She has focused on personalized medicine and developed individual risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored over 1,800 peer-reviewed articles. Dr. Mehran currently serves as member and 2025-2026 Vice President on the Board of Trustees of The American College of Cardiology (ACC). She is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation (CRF). She ranked 36^th in the “Best Female Scientists in the World” and has been included for the past eight consecutive years in Clarivate Analytics:  “Most Cited Researchers – Top 1%” as well as “The World’s Most Influential Scientific Minds”.

Dr. Mehran is leading the Lancet Commission on Women’s Cardiovascular Diseases, which has brought together leading researchers from around the world to identify and bridge gaps in scientific discovery, clinical trials, and care for women with cardiovascular disease.  She was recently named Director of the Women Heart and Vascular Center at Mount Sinai Heart, spearheading a new program that represents a collaboration across multiple disciplines and designed to meet the unique needs of women’s cardiovascular health. In 2019, she founded Women as One, a not for profit organization, dedicated to advancing opportunities for women in medicine, where she serves as Chair of the Board.

Dr. Mehran is a recipient of several awards including the 2016 American College of Cardiology Bernadine Healy Leadership in CV disease award, the 2018 Nanette Wenger Award from Women’s Heart for excellence in research and education, the 2019 Ellis Island Medal of Honor, and the 2019 European Society of Cardiology Silver Medal and Andreas Grüntzig Lecture plaque. In 2022, she received The Terry Ann Krulwich Physician-Scientist Alumni Award at Mount Sinai; the Linda Joy Pollin Heart Health Leadership Award from Cedar Sinai Medical Center; Doctor Honoris Causa Degree at Università della Svizzera Italiana; Women in Cardiology Mentoring Award from American Heart Association; and the Pulse-Setter Champion Award from The Cardiovascular Research Foundation. On March of 2024 she was honored with the Jacobi Medal, top achievement award from Icahn School of Medicine at Mount Sinai.